Stock Price Updates, Earnings Releases, and Dividend Declarations - Analyst Notes on ExxonMobil, Core, Vale, Peabody Energy and Baker Hughes

NEW YORK, May 15, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Exxon Mobil Corporation (NYSE: XOM), Core Laboratories NV (NYSE: CLB), Vale S.A. (NYSE: VALE), Peabody Energy Corp. (NYSE: BTU) and Baker Hughes Incorporated (NYSE: BHI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2488-100free.

Exxon Mobil Corporation Analyst Notes
On May 12, 2014, shares of Exxon Mobil Corporation (ExxonMobil) gained 0.27% to end the trading session at $102.23, and in line with the Dow Jones Industrial Average (DJIA), which rose 0.68% to settle at 16,695.47. The stock of ExxonMobil opened at $102.33 and fluctuated in the range of $102.35 - $101.52. A total of 8.83 million shares were traded, lower than the 30-day average trading volume of 10.80 million shares. Over the past 12-months, the stock has gained 13.41%, versus DJIA which returned 10.43% during the same time period. Notably, ExxonMobil's stock began trading ex-dividend on May 9, 2014. A cash dividend payment of $0.69 per share is scheduled to be paid on June 10, 2014. Shareholders who purchased ExxonMobil's stock prior to the ex-dividend date of May 9, 2014 are eligible for the cash dividend payment. The full analyst notes on ExxonMobil are available to download free of charge at:

http://www.analystsreview.com/2488-XOM-15May2014.pdf

Core Laboratories NV Analyst Notes
On May 12, 2014, shares of Core Laboratories NV (Core) tanked 11.68% to end the trading session at $167.02, after the Company lowered its earnings and revenue guidance for Q2 FY 2014 and FY 2014. The Company now expects Q2 FY 2014 earnings of $1.32-$1.35 per share on revenue of $265 million - $270 million versus its prior projections of $1.48 - $1.53 per share on $280 million-$286 million. According to Core, the downward revision in Q2 FY 2014 revenue and EPS guidance was primarily caused by North American clients that now project sampling and analyzing less than previously expected levels of reservoir fluids from established unconventional plays in the Marcellus, Bakken, Montney, Niabrara and Eagle Ford formations. For FY 2014, the Company now sees EPS of $5.80 to $6.00 on revenue of $1.1 billion, down from its prior earnings guidance of $6.00-$6.25 per share on $1.15 billion-$1.17 billion. The full analyst notes on Core are available to download free of charge at:

http://www.analystsreview.com/2488-CLB-15May2014.pdf

Vale S.A. Analyst Notes
On May 12, 2014, the ADRs of Brazilian mining Company, Vale S.A. (Vale) jumped 4.16% to end the trading session at $13.78, on the back of rally in commodities. The ADR opened at $13.53 and touched an intraday high of $13.82 and a low of $13.50. A total of 26.52 million ADRs changed hands, higher than the previous day's trading volume of 17.35 million ADRs. On April 30, 2014, Vale reported its Q1 2014 earnings. Q1 2014 earnings per ADR came in at 40 cents (on a fully-diluted basis), down 33.9% YoY and 36.3% sequentially, which also missed the Zacks consensus estimate of 52 cents per ADR. The full analyst notes on Vale are available to download free of charge at:

http://www.analystsreview.com/2488-VALE-15May2014.pdf

Peabody Energy Corp. Analyst Notes
On May 12, 2014, shares of Peabody Energy Corp. (Peabody Energy) ended the trading session at 19.11, up 2.41% from its previous day's close. A total of 14.11 million shares were traded, significantly higher than the 30-day average trading volume of 8.44 million shares. A news article on CNBC, reported that analysts at Morgan Stanley upgraded the stock to "overweight" from "equalweight" with a revised price target of $30.0, indicating an upside of nearly 57% from current levels. The full analyst notes on Peabody Energy are available to download free of charge at:

http://www.analystsreview.com/2488-BTU-15May2014.pdf

Baker Hughes Incorporated Analyst Notes
On May 9, 2014, Baker Hughes Incorporated (Baker Hughes) announced that the Board of Directors declared a regular quarterly cash dividend of $0.17 per share of common stock payable August 15, 2014, to holders of record on August 4, 2014. The dividend represents a 2 cents increase per share over the previous quarter's dividend of $0.15 per share of common stock. Commenting on the dividend declaration, Martin S. Craighead, Chairman and CEO of Baker Hughes, said "The increase to our dividend is a result of recent earnings growth, and reflects our commitment to deploy capital in a way which best benefits our shareholders." The full analyst notes on Baker Hughes are available to download free of charge at:

http://www.analystsreview.com/2488-BHI-15May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.analystsreview.com/

SOURCE Analysts Review